Join us on this live lab tour to learn how Sapient’s next-generation, ultra-high throughput rapid liquid chromatography-mass spectrometry (rLC-MS) platform leverages the unique bioanalytical capabilities of the Bruker timsTOF Pro 2 to enable large-scale biomarker profiling. See how the systems perform nontargeted measurement of >11,000 circulating small molecule biomarkers per biosample across thousands of samples at a time.
Discover how these instruments offer:
The Sapient team will also show you how these technologies are embedded within a larger integrated discovery pipeline that allows for rapid identification and cross-validation of new biomarkers across broad, diverse populations.
Mohit Jain, M.D., Ph.D., Founder and CEO, Sapient, San Diego, CA, USA
Jeramie Watrous, Ph.D., Co-Founder and Head of Analytical R&D, Sapient, San Diego, CA, USA
For Research Use Only. Not for use in clinical diagnostic procedures.